AD-17002

N/A

Report date: 2025/09/11 20:00:08

Base Information

Drug NameAD-17002
Drug Alias NameLTh(αK)AD17002-SCAD-17002DCB 07010
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Eosinophilia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanIndonesia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAdvagene Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdvagene Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Eosinophilia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A